ABOS vs IMDX
Comparison between Acumen Pharmaceuticals Inc (ABOS, Company) and Insight Molecular Diagnostics Inc (IMDX, Company).
Both ABOS and IMDX are from the Healthcare sector.
5-Year PerformanceABOS has outperformed IMDX, delivering a return of -31.6% compared to -44.8%
ABOS vs IMDX - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
ABOS vs IMDX - Historical Returns
Returns include dividend reinvestment.
ABOS vs IMDX - Annual Returns (2016 - 2026)
Returns include dividend reinvestment.
| Year | ABOS | IMDX |
|---|---|---|
| 2026 | +10.89% | -30.17% |
| 2025 | +14.05% | +221.89% |
| 2024 | -59.34% | -27.88% |
| 2023 | -27.00% | -63.77% |
| 2022 | -19.76% | -85.74% |
| 2021 | -66.37% | -9.21% |
| 2020 | N/A | +7.17% |
| 2019 | N/A | +53.06% |
| 2018 | N/A | -70.00% |
| 2017 | N/A | -31.11% |
| 2016 | N/A | -21.67% |
ABOS vs IMDX Drawdown Comparison
The maximum drawdown for ABOS was -95.56%, occurring on Apr 17, 2025. This drawdown has not yet recovered.
The maximum drawdown for IMDX was -99.03%, occurring on Jan 22, 2025. This drawdown has not yet recovered.
The current ABOS drawdown is -88.95%. The current IMDX drawdown is -97.53%.
| Rank | ABOS | IMDX |
|---|---|---|
| #1 | -95.56% Jul 2, 2021 - Apr 17, 2025 | -99.03% Jan 5, 2016 - Jan 22, 2025 |
Correlation
Correlation between ABOS and IMDX is 0.87 which considered as a strong positive correlation - the stocks tend to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks